ScholarIQanswers from OpenAlex & ORCID
Arnaud Scherpereel
ResearcherPublications, citations & collaboration network
Arnaud Scherpereel is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Arnaud Scherpereel have?
ScholarIQindexed works
Arnaud Scherpereel has 463 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Arnaud Scherpereel have?
ScholarIQcitation count
Arnaud Scherpereel has 19,026 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Arnaud Scherpereel?
ScholarIQh-index
Arnaud Scherpereel has an h-index of 66 in OpenAlex.
What is the i10-index of Arnaud Scherpereel?
ScholarIQi10-index
Arnaud Scherpereel has an i10-index of 173 in OpenAlex.
What is the ORCID of Arnaud Scherpereel?
ScholarIQorcid
The ORCID for Arnaud Scherpereel is on the source record.
What is the OpenAlex record for Arnaud Scherpereel?
ScholarIQopenalex
The OpenAlex for Arnaud Scherpereel is on the source record.
What are the most-cited papers on Arnaud Scherpereel?
ScholarIQmost cited works
First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial
Paul Baas, Arnaud Scherpereel, Anna K. Nowak, Nobukazu Fujimoto, Solange Peters, Anne S. Tsao, Aaron S. Mansfield, Sanjay Popat, Thierry Jahan, Scott Antonia, Youssef Oulkhouir, Yolanda Bautista, Robin Cornelissen, Laurent Greillier, Francesco Grossi, Dariusz M. Kowalski, Jerónimo Rafael Rodríguez‐Cid, Praveen Aanur, Abderrahim Oukessou, Christine Baudelet, Gérard Zalcman
Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial
Gérard Zalcman, Julien Mazières, J. Margery, Laurent Greillier, Clarisse Audigier-Valette, Denis Moro‐Sibilot, Olivier Molinier, R. Corre, I. Monnet, V. Gounant, F. Rivière, Henri Janicot, Radj Gervais, Chrystèle Locher, B. Milleron, Quan Le Tran, Marie-Paule Lebitasy, Franck Morin, Christian Créveuil, Jean‐Jacques Parienti, Arnaud Scherpereel
Updated Overall Survival and PD-L1 Subgroup Analysis of Patients With Extensive-Stage Small-Cell Lung Cancer Treated With Atezolizumab, Carboplatin, and Etoposide (IMpower133)
Stephen V. Liu, Martin Reck, Aaron S. Mansfield, Tony Mok, Arnaud Scherpereel, Niels Reinmuth, Marina Chiara Garassino, Javier de Castro, Raffaele Califano, Makoto Nishio, Francesco Orlandi, Jorge Alatorre-Alexander, Ticiana Leal, Ying Cheng, Jong Seok Lee, Sivuonthanh Lam, Mark L. McCleland, Yu Deng, See Phan, Leora Horn
Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer
Lisa Derosa, Bertrand Routy, Andrew Maltez Thomas, Valerio Iebba, Gérard Zalcman, S. Friard, Julien Mazières, Clarisse Audigier-Valette, Denis Moro‐Sibilot, François Goldwasser, Carolina Alves Costa Silva, Safae Terrisse, Mélodie Bonvalet, Arnaud Scherpereel, Hervé Pegliasco, Corentin Richard, François Ghiringhelli, Arielle Elkrief, Antoine Desîlets, Félix Blanc‐Durand, Fabio Cumbo, Aitor Blanco‐Míguez, Romain Boidot, Sandy Chevrier, Romain Daillère, Guido Kroemer, Laurie Alla, Nicolas Pons, Emmanuelle Le Chatelier, Nathalie Galleron, Hugo Roume, Agathe Dubuisson, Nicole Bouchard, Meriem Messaoudene, Damien Drubay, Éric Deutsch, Fabrice Barlési, David Planchard, Nicola Segata, Stéphanie Martinez, Laurence Zitvogel, Jean‐Charles Soria, Benjamin Besse
Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial
Arnaud Scherpereel, Julien Mazières, Laurent Greillier, Sylvie Lantuéjoul, Pascal Dô, Olivier Bylicki, I. Monnet, R. Corre, Clarisse Audigier-Valette, M. Locatelli-Sanchez, Olivier Molinier, Florian Guisier, T. Urban, Catherine Ligeza‐Poisson, David Planchard, Elodie Amour, Franck Morin, Denis Moro‐Sibilot, Gérard Zalcman, D. Debieuvre, Sandrine Hiret, Jacques Cadranel, S. Fraboulet-Moreau, D. Carmier